| 000 | 01573 a2200469 4500 | ||
|---|---|---|---|
| 005 | 20250515111341.0 | ||
| 264 | 0 | _c20080723 | |
| 008 | 200807s 0 0 eng d | ||
| 022 | _a1476-5594 | ||
| 024 | 7 |
_a10.1038/onc.2008.19 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aWheeler, D L | |
| 245 | 0 | 0 |
_aMechanisms of acquired resistance to cetuximab: role of HER (ErbB) family members. _h[electronic resource] |
| 260 |
_bOncogene _cJun 2008 |
||
| 300 |
_a3944-56 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 |
_aAntibodies, Monoclonal _xchemistry |
| 650 | 0 | 4 | _aAntibodies, Monoclonal, Humanized |
| 650 | 0 | 4 |
_aAntineoplastic Agents _xpharmacology |
| 650 | 0 | 4 | _aCell Line, Tumor |
| 650 | 0 | 4 | _aCetuximab |
| 650 | 0 | 4 | _aDrug Resistance, Neoplasm |
| 650 | 0 | 4 | _aEndocytosis |
| 650 | 0 | 4 |
_aErbB Receptors _xgenetics |
| 650 | 0 | 4 | _aGene Expression Regulation, Neoplastic |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aModels, Biological |
| 650 | 0 | 4 |
_aNeoplasms _xdrug therapy |
| 650 | 0 | 4 | _aRNA Interference |
| 650 | 0 | 4 |
_aReceptor, ErbB-2 _xmetabolism |
| 650 | 0 | 4 |
_aReceptor, ErbB-3 _xmetabolism |
| 700 | 1 | _aHuang, S | |
| 700 | 1 | _aKruser, T J | |
| 700 | 1 | _aNechrebecki, M M | |
| 700 | 1 | _aArmstrong, E A | |
| 700 | 1 | _aBenavente, S | |
| 700 | 1 | _aGondi, V | |
| 700 | 1 | _aHsu, K-T | |
| 700 | 1 | _aHarari, P M | |
| 773 | 0 |
_tOncogene _gvol. 27 _gno. 28 _gp. 3944-56 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1038/onc.2008.19 _zAvailable from publisher's website |
| 999 |
_c17800921 _d17800921 |
||